Summary The present study was undertaken to compare the relationship between response to exogenous epidermal growth factor (EGF) and the expression of the EGF-receptor (EGF-R) in an androgen sensitive (LNCaP) and insensitive (DU145) prostate cancer cell line. Although both cell lines demonstrated a single EGF-R binding site of similar high affinities (mean dissociation constant (Kd) ± S.D. for DU145 = 1.0 ± 0.6 nmol 1-'; LNCaP = 2.8 2.2 nmol 1') the number of binding sites (RT) for the hormone insensitive DU145 cells (mean ± S.D. = 2.5 1.0 x 105 sites/cell) and 10-fold greater than that expressed in the androgen responsive LNCaP cell line (mean ± S.D. = 2.0 ± 1 x 104 sites/cell). Additionally exogenous EGF only minimally affected the growth and DNA synthesis of DU145 cells whereas LNCaP cells showed a significant response which was dose dependent. The autologous production of EGF-like molecules by DU145 cells is believed to reduce the cells needs for exogenous mitogens, thereby rendering the cells autostimulatory. Treatment of LNCaP cells with Mibolerone -a synthetic androgen -did not affect either the expression of the EGF receptor or the proliferative response observed with EGF. Western blot analysis, using monoclonal antibodies directed against the EGF receptor revealed a band of approximately 170 kD with DU 145 cell lysates but the LNCaP EGF receptor was not detected using this technique.
In the early stages, prostate cancer growth is almost always androgen dependent, but eventually the tumour progresses to a more aggressive state in which growth is androgen independent (Griffiths et al., 1987) . This transition is a major obstacle to successful treatment not only of carcinoma of the prostate but also in many other tumours originating from hormone responsive tissues (Hodges, 1979; Lippman, 1984) .
The role of EGF and its receptor as a mediator of prostate cancer cell growth has in recent years come under intense investigation. Many workers are now coming to recognise growth factors as playing a major role in the progression of androgen dependent to androgen independent prostate cancer cell growth, though the evidence in the literature remains contradictory and no clear pattern is emerging: Initially the expression of EGF receptor messenger RNA was demonstrated in the androgen independent PC3 human prostate cancer cell line (Derynck et al., 1987) but subsequently the presence of EGF-R was also confirmed in the androgen sensitive LNCaP cells (Schuurmans et al., 1988) . However, the evidence for the modulation of EGF-R by androgen is not conclusive and whether the steroid hormone up regulates (Schuurmans et al., 1988) or down regulates (Traish & Wotiz, 1987; St-Arnaud et al., 1988 ) the EGF-R varies and depends on the type of experiments carried out. Furthermore, the response may also reflect the species from which the prostate cells were derived (Schuurmans et al., 1988; Traish & Wotiz, 1987; St-Arnaud et al., 1988) . This complex relationship between steroid hormone and growth factors is not exclusive to the prostate gland, but has been observed in other hormone dependent organs. In breast cancer where a detailed study has been carried out on the interaction between oestrogens, progestins and growth factors and how they may act together to regulate cell proliferation, oestrogens have been shown to affect the production of TGF-(x (Dickson et al., 1986) , and suppress the secretion of inhibitory growth factors (Knabbe et al., 1987) whereas progestins modulate epidermal growth factor receptor expression (Murphy et al., 1986) .
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vincing there are also suggestions that the progession to oestrogen independent breast cancer cell growth may be the result of a change in the activity of the growth factor or its receptor (King, 1990) (Gullick et al., 1986 Detection of the EGF receptor and the v-erbB gene product by Western blotting Cell monolayers (5 x 107 cells) were washed with Dulbecco 'A' PBS and pelleted by gentle centrifugation (5 min at 1,500 r.p.m.). The cell pellet was then lysed with 2 ml of 50 mmol 1' Tris-HCI buffer, pH 7.4, containing 1% v/v of Triton X-100, 150 mmol l' of NaCl, 25 mmol -' of Benzamidine, 0.1% of BSA, 0.3mmoll1' of phenylmethylsulphonylfluo-ride, 1 mmol I`of dithiothreitol and 10% of glycerol and centrifuged at 3,000 r.p.m. for 30 min. Sample buffer (400 "l) containing P-mercaptoethanol was added to the soluble cellular material (100 Jl), the samples heated to 100°C for 3 min and electrophoresed on 7.5% polyacrylamide gels containing sodium dodecylsulphate.
After blotting on to a nitrocellulose membrane the strips were blocked with 5% (w/v) skimmed milk solution for 10 min at room temperature, rinsed in washing buffer (50mmoll'-of Tris, 150 mmoll1 of NaCl, 2mmoll' of EDTA at pH 7.5) and incubated with MAb F4 (2 pg), with 2% BSA in washing buffer, for 2 h with continual shaking at room temperature. A mouse MAb, raised against MHC IgG class 2 was used as a non specific control. The strips were then rinsed in washing buffer and incubated with alkaline phosphatase antibody conjugate mouse IgG (Sigma) for 2 h at room temperature. The strips were rinsed once more in washing buffer and developed by the addition of Naphtholphosphate (15 mg Naphthol -AS-MX-phosphate (free acid) in 1.5 ml dimethylformamide, added to 75 ml saline/0.05 mol 1-l Tris, pH 8.8 with 75 mg Fast Red TR salt; Sigma. The development of the colour product was terminated by rinsing in water.
Data analysis
The computer analysis employed for competition and saturation was the weighted, nonlinear least-squares curve fitting program LIGAND (DeLean et al., 1978; Munson & Rodbard, 1980) Figures la and b) . The data for DUI45 were analysed using the curve fitting program LIGAND and fitted significantly to one class of binding site (P<0.05), with an estimated Kd ± S.D. value of 1.0 ± 0.5 nmol 1-'. The number of binding sites/cell ± S.D. was calculated as 2.0 x 105 ± 8 x 104. The dissociation constant ± S.D. of the EGF receptors in LNCaP cells was calculated as 2.9 ± 2.2 nmol 1' and the number of receptor binding sites/cell ± S.D. as 2.5 ± 1.3 x 104; almost 10-fold lower than DUI45 cells.
Overall the dissociation constant and binding capacity for DU145 monolayers were 1.0 ± 0.6 nmol 1' and 2.5 ± 1 x 105 sites/cell respectively. The number of binding sites for LNCaP cells was considerably less (2.0 ± 1 x 104). The dissociation constant of 2.8 ± 2.2 nmol I`was lower overall, but was not significantly different from DUI45 cells (P<0.05). Dulbecco 'A' PBS to separate bound '251I-EGF from free 1251I EGF, the cells were subsequently dissolved in 0.5 N NaOH and the radioactivity remaining was evaluated. LNCaP monolayers were pelleted, spun and the remaining radioactivity measured.
The dissociation constant and the number of EGF binding sites were determined by the binding program LIGAND. Ten saturation curves were analysed from DU145 and six from LNCaP cells. (Figure 3a) . In contrast to EGF's effect on DU145 proliferation, LNCaP cell numbers were significantly increased. EGF exerted a biphasic effect on proliferation with concentrations up to 0.3 nmol I`enhancing proliferation by 98% ± 6 relative to control values (P<0.001) and higher concentrations abolishing this stimulatory effect (Figure 3b ).
Effect of EGF on 3H-thymidine incorporation
In a parallel study the impact of EGF on 3H-thymidine incorporation was investigated (Figures 4a and b) . After 24 h, EGF stimulated 3H-thymidine incorporation in DU145 cells in a dose dependent manner, with maximum incorporation observed at an EGF concentration of 1 nmol I( 26% ± 13; P<0.001). EGF also stimulated DNA synthesis in LNCaP cells in a dose dependent fashion, with the maximal effect observed with 0.3 nmol 1`of EGF; increasing 3H-thymidine incorporation by 78 ± 10% (P<0.001). Furthermore a dosedependent decrease in 3H-thymidine incorporation was noted with concentrations greater than 0.3 nmol 1' (Figure 4b added to SFM cultures of LNCaP cells with and without EGF, for a period of 6 days and the cells counted after this time (Figure 5a ) or for 24 h and incorporation of 3H-thymidine measured (Figure 5b ). EGF and Mibolerone independently increased cell proliferation by 82% ± 18 (P<0.001) and 51% ± 8.5 (P<0.02) respectively. However the stimulation in thymidine incorporation following the addition of EGF was less than the recent increase in cell number (98% ± 6) but this difference may simply reflect the statistical variation of the systems used. The addition of EGF and Mibolerone together to LNCaP cells did not produce a greater stimulatory effect than EGF alone (77% ± 12); that is the effect on proliferation was not additive (Figure 5a) . A similar effect was observed on DNA synthesis; EGF and Mibolerone independently stimulated DNA synthesis by 80% ± 10 and 70 ± 14% respectively (P<0.001). However, this response was not additive as EGF and Mibolerone added together did not increase 3H-thymidine incorporation above 79% ± 8 ( Figure  Sb) .
Discussion
In this study the comparison of the prostatic cancer cell lines DU145 and LNCaP provided a useful in vitro model for the study of EGF receptor expression and the mitogenic effect of EGF in prostatic cancer in an androgen-responsive and androgen-unresponsive state.
Competition and saturation analysis revealed that both cell lines possess EGF receptors with one high affinity binding site, consistent with the earlier findings for LNCaP cells (Schuurmans et al., 1988) and DU145 cells (Wilding et al., 1989 ) although other studies (Connolly & Rose, 1989) 1988 ; Wilding et al., 1989) in which other workers detected a 2-fold increase in the number of EGF receptors upon treatment of LNCaP cell with androgens. However, the increases observed were relatively small and neither group reported any statistical analysis of their data. Therefore it remains questionable whether the EGF receptor is up-regulated by steroid hormones in LNCaP cells. Indeed, in the normal rat prostate it was found that EGF receptor levels are down regulated by androgens (Traish & Wotiz, 1987; St-Arnaud et al., 1988) . It is therefore not inconceivable that the interaction between androgens and the EGF receptor in the normal prostate may be lost, resulting in neoplastic growth.
Although DU145 cells possess large numbers of EGF receptors, exogenous EGF had very little effect on the growth and incorporation of 3H-thymidine in these cells. In contrast, EGF elicited a substantial mitogenic response on the androgen sensitive LNCaP cell line and this was dosedependent; A 2-fold increase in cell numbers and 3H-thymidine incorporation into DNA was induced following treatment with 3 nmol of EGF. A similar mitogenic effect by EGF was also reported in earlier studies (Schuurmans et al., 1988; Wilding et al., 1989) .
In common with the findings on breast cancer cell lines (Davidson et al., 1987) we observed a negative correlation between the expression of the EGF receptor and the mitogenic response to exogenous EGF. Like DU145 and LNCaP cell lines, the presence of relatively low numbers of EGF receptors on breast cancer cell lines was associated with the 300 .. 
